SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001401914-22-000087
Filing Date
2022-11-10
Accepted
2022-11-10 16:03:06
Documents
55
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q dare-20220930.htm   iXBRL 10-Q 1107168
2 EX-31.1 exhibit311_20220930.htm EX-31.1 15481
3 EX-31.2 exhibit312_20220930.htm EX-31.2 15237
4 EX-32.1 exhibit321_20220930.htm EX-32.1 4352
5 EX-32.2 exhibit322_20220930.htm EX-32.2 4340
11 dare-20220930_g1.jpg GRAPHIC 130914
  Complete submission text file 0001401914-22-000087.txt   5447983

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT dare-20220930.xsd EX-101.SCH 44977
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT dare-20220930_cal.xml EX-101.CAL 37326
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT dare-20220930_def.xml EX-101.DEF 194537
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT dare-20220930_lab.xml EX-101.LAB 493107
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT dare-20220930_pre.xml EX-101.PRE 299842
49 EXTRACTED XBRL INSTANCE DOCUMENT dare-20220930_htm.xml XML 692253
Mailing Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122
Business Address 3655 NOBEL DRIVE SUITE 260 SAN DIEGO CA 92122 858-926-7655
Dare Bioscience, Inc. (Filer) CIK: 0001401914 (see all company filings)

IRS No.: 204139823 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-36395 | Film No.: 221376953
SIC: 2834 Pharmaceutical Preparations